Atypical Teratoid/Rhabdoid Tumor — Trials

Atypical Teratoid/Rhabdoid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Seattle Children's Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04521946	Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer	withdrawn	Phase 1	0	M.D. Anderson Cancer CenterOTHER	0	Oct 26, 2024	clinicaltrials
NCT05952687	Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors	withdrawn	Phase 1	0	St. Jude Children's Research HospitalOTHER	0	Mar 27, 2024	clinicaltrials